| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5546213 | Current Opinion in Virology | 2017 | 9 Pages |
â¢Silencing of viral and cellular genes are promising antiviral strategies.â¢Genome editing nucleases can inactivate or reactivate integrated viral genomes.â¢Roadblocks are off-target effects, efficient delivery and induction of immune response.â¢Viral resistance is a major concern to genome silencing as antiviral strategy.
The ability of some viruses to establish latently infected chronic reservoirs that escape to immune control becomes a major roadblock that impedes the cure of these infections. Therefore, new alternatives are needed to pursuit the eradication of viral persistent infections. Gene silencing technologies are in constant evolution and provide an outstanding sequence specificity that allows targeting any coding sequence of interest. Here we provide an overview of the development of gene silencing technologies ranging from initially RNA interference to the recently developed CRISPR/Cas9 and their potential as new antiviral strategies focusing on the eradication of HIV.
